Felipe A. Martinez
Cordoba, X, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 173 publications
Comparative Prognosis of Chagas and Other Cardiomyopathies.
Journal: Journal of the American College of Cardiology
Published: February 09, 2026
Interchangeability of the KCCQ-12 and KCCQ-23 Across >18,000 Participants Enrolled in 4 Large-Scale Trials of Heart Failure.
Journal: Journal of the American College of Cardiology
Published: January 15, 2026
Self-Administered Etripamil Nasal Spray Slows Ventricular Rate in Patients With Atrial Fibrillation: A Post Hoc Analysis of the NODE-303 Study.
Journal: Journal of cardiovascular electrophysiology
Published: October 09, 2025
Race and Ethnicity in Heart Failure Trials: Time to Update Recommended Categories for Global Relevance.
Journal: Journal of the American Heart Association
Published: June 11, 2025
Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical Trial.
Journal: JAMA cardiology
Published: June 04, 2025
Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: April 29, 2025
Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial.
Journal: Cardiovascular diabetology
Published: April 28, 2025
Growth Differentiation Factor-15 and the Effect of Dapagliflozin in Heart Failure: Insights From the DAPA-HF Trial.
Journal: Journal of cardiac failure
Published: March 14, 2025
Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection Fraction.
Journal: JACC. Heart failure
Published: January 28, 2025
Last Updated: 09/26/2026